Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-26

Clinical Trial Update: Assessment of Health-status of Patients With Chronic Obstructive Pulmonary Disease (COPD) on Maintenance Therapy With Spiriva HH Measured by COPD Assessment Test (CAT) Test [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the health status of COPD patients on maintenance Spiriva tiotropium using the COPD Assessment Test (CAT).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SPIRIVA HANDIHALER (TIOTROPIUM BROMIDE)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED | Results posted: 2014-05-26